Introduction
============

In clinical settings, sepsis always occurs secondary to severe infection, trauma, burn, and major surgery. Severe sepsis and septic shock can lead to multiple organ dysfunction syndromes and death. The annual death frequency caused by sepsis can reach 100,000 worldwide, and the cost of treatment can reach tens of billions of dollars ([@b1-etm-0-0-3354]). The abnormal immune mechanism in sepsis has become a hot research topic and macrophages that play an important role in antigen presentation in the process of organism immunity, constitute a communication bridge. According to the condition of induced differentiation, macrophages can be classified to M1 type or M2 macrophage, both of which have different activation pathways, producing a series of cytokines and inducing organism immune response to change toward different directions after activation ([@b2-etm-0-0-3354]). Previous findings have shown that Th2 immune response is enhanced in patients with trichinellosis, even manifesting as immunosuppression. This type of change can remit the occurrence of immune disease ([@b3-etm-0-0-3354]). Due to high risk and potentially lethal trichinization, the application of the recombinant *Trichinella* protein may bring new research directions for use in immune diseases ([@b4-etm-0-0-3354]).

Materials and methods
=====================

### Experimental animals

Eighteen clean Sprague-Dawley (SD) rats (Shanghai Shenggong Technology Co., Ltd., Shanghai, China) from the same race and brood, aged 6--8 weeks with a weight of 190±10 g, were selected and randomly divided into the sham operation (n=5), control (n=5) and experimental (n=8) groups. Differences pertaining to comparison among age, weight and health state were not statistically significant (P\>0.05). The rats in the sham operation group underwent cecum division and suture with routine therapy for cure. The rats in the control and experimental groups underwent cecal ligation and puncture (CLP). The experimental group was given recombinant *Trichinella* 53-kDa protein in advance, and the control group was given the same dose of placebo.

### Preparation of the CLP rat model

Preoperative abrosia was carried out for 12 h, with isoflurane inhalation anesthesia to induce and maintain the anesthesia state of the rats. The rats were placed in supine position, the skin of hypogastrium was disinfected with iodine, and the rats underwent direct shear operation to cut the skin, muscular layer and peritoneum gradually below the middle of linea alba approximately 0.3 cm. Using a tweezer the muscle layer was lifted to explore the abdominal cavity, and the end of appendix was removed and placed outside of the abdominal wall, then ligatured 1.6 cm from the cecum end with the suture line. Two holes were punctured vertically to the cecum, which was then drained. The cecum was returned to the abdominal cavity and the abdomen was sutured. An immediate neck and back subcutaneous injection of 50 ml/kg compound sodium chloride was carried out and the rats were placed in the cage. The rats were given water and food after 4 h. The animals were kept indoors at a temperature of 20±1°C, humidity 60±10% and light from 6:00 a.m. to 6:00 p.m. ([@b5-etm-0-0-3354]).

Approval for the animal studies was received from the ethics committee of the Second Hospital of Dalian Medical University.

### Preparation and depuration of decombinant Trichinella 53-kDa protein

The prepared pET-28a(+)-TsP53-*E. coli* BL21 glycerine bacteria were defrosted, inoculated and merged in 3 ml LB liquid medium for culture. Kanamycin solution (3 µl) was then added, single distributed bacteria were selected for cloning, and the culture was agitated for 12 h. When the culture medium was turbid, the liquid was obtained and the culture continued. Subsequently, 3 ml 1 M IPTG inducer was added, followed by lysating it on ice using ultrasound pyrolysis apparatus (Nanjing Xianou Instrument Manufacturing Co., Ltd., Nanjing, China), the supernatant was discarded and the sediment was kept after three cycles of centrifugation at 3,000 × g for 20 min. Then, 30 ml 8 M urea solution was added to the sediment and was resuspended, which was placed on a shaker to clear the liquid. The supernatant was obtained by filtering the 0.45 µm microporous membrane (Xi\'an DingChang Co., Ltd., Xi\'an, China), as the chromatographic sample of Ni-NTA-HIS metal chelate. The dialyzed protein sample was added to the ToxinEraser™ endotoxin to remove the resin chelating for 1 h, prior to being eluted. The process was repeated to condense the rTsP53 protein sample ([@b6-etm-0-0-3354]).

### Preparation of rat anti-rTsP53 protein polyclonal antibody

A quantity of 200 µg purified rTsP53 protein sample was emulsified in Freund\'s complete adjuvant, which was then injected into the SD rats subcutaneously, at 3 and 5 weeks. The peripheral blood of the animals was kept and the rTsP53 protein antibody was detected using ELISA ([@b7-etm-0-0-3354]).

### Detection of bone marrow-derived macrophages (BMDMs) M1 and M2

The rats were sacrificed by cervical dislocation, and an annular incision was performed under the abdominal skin of rats, with the lower limb skin by blunt separation. The knee joint was cut, and the connection of the hip and spine was examined by careful separation to expose the femur and hip. The partial, residual muscle and tendon tissue were removed. The two ends of the bone were cut, one of which was injected with 2.5 ml Dulbecco\'s modified Eagle\'s medium (DMEM) without any sodium pyruvate using a 2.5 ml syringe needle. The marrow tissue was placed in a 15 ml centrifuge tube with medium liquid, until the marrow cavity became white. The supernatant of 30% L929 cell culture medium and the cells were added. The cells were cultivated at 7°C, in a 5% CO~2~ environment for 96 h, changing the liquid and removing the components that did not adhere. Macrophage BMDMs of the bone marrow were obtained ([@b8-etm-0-0-3354]). Then, induced differentiation of the macrophages were carried out as per the instructions.

The survival rate difference of the rats was analyzed at 6 and 12 h, and proportion of the macrophages expressed among the groups. The expression level of Th1-type cytokines IFN-γ and tumor necrosis factor (TNF)-α, as well as Th2-type cytokines interleukin-4 (IL-4) and IL-13 were compared.

### Statistical analyis

Data were analyzed using SPSS 19.0 statistical software (SPSS Inc. Chicago, IL, USA). Data were presented as mean ± standard deviation. Comparison between groups were carried out using the t-test. Countable data were expresses as cases or percentage, and comparison of groups were carried out using the Chi-square (χ^2^) test. P\<0.05 was statistically significant.

Results
=======

### Comparison of the survival rates in three groups of rats

The survival rate of rats in the experimental group was higher than that of the control group at 6 and 12 h, and the difference was statistically significant (P\<0.05) ([Table I](#tI-etm-0-0-3354){ref-type="table"}).

### Comparison of the expression ratio of macrophages

After 72 h of the blank medium, we obtained PE-CCR7(−), FITC-CD206(−) macrophages (A group). Through the activation of 20 ng/ml IFN-γ for 72 h, we obtained PE-CCR7(+) macrophages (B group). Through the activation of 10 ng/ml IL-3/IL-14 for 72 h, we obtained FITC-CD206(+) macrophages (C group); following culture with rTsP53 protein for 72 h, we obtained FITC-CD206(+) macrophages (D group); and following culture of 20 µg/ml IFN-γ and 5 µg/ml rTsP53 protein for 72 h, we obtained PE-CCR7(+) macrophages (E group). The expression ratio of the macrophage in the experimental group was higher than that of the control group, and the difference was statistically significant (P\<0.05) ([Table II](#tII-etm-0-0-3354){ref-type="table"}).

### Comparison of the expression level of Th1- and Th2-type cytokines

The expression level of the Th1-type cytokines IFN-γ and TNF-α of the experimental group was higher than that of the control group, while the expression level of the Th2-type cytokines IL-4 and IL-13 was higher in the control group. The difference was statistically significant (P\<0.05) ([Table III](#tIII-etm-0-0-3354){ref-type="table"}).

Discussion
==========

Clinical studies ([@b9-etm-0-0-3354],[@b10-etm-0-0-3354]) suggesting that an abnormal immune mechanism leading to excessive activation of the organism inflammation/anti-inflammatory reaction process can cause tissue damage or immune paralysis has become an important field of investigation in sepsis research. A new treatment concept of immunomodulation has emerged as a result. Macrophages serve as antigens presenting in the body\'s immune process, and a series of cytokines that macrophages produce further regulate the body\'s immune reaction process. Therefore, the study of macrophages and immune response may identify the deeper mechanisms of the occurrence and development of sepsis, leading to new treatments and concepts ([@b11-etm-0-0-3354],[@b12-etm-0-0-3354]).

### Function of abnormal immunologic mechanism on sepsis

Anti-inflammatory media have been used to study animals with sepsis, for example, classic TNF-α, with the result showing that the anti-inflammatory medium treatment by TNF-α is able to improve the prognosis of partial sepsis in animals ([@b13-etm-0-0-3354]). At the same time, previous findings showed ([@b14-etm-0-0-3354]) that besides the classic inflammatory medium, IL-4, IL-10 and IL-13 improved significantly patients with SIRS. Due to the findings of early inflammation/anti-inflammatory medium research, it was found that intervention by single regulation of inflammation/anti-inflammatory cytokine did not correct perfectly the prognosis of sepsis. Since a complicated intervention network of each other existed in inflammation/anti-inflammatory cytokines, similar to the waterfall release of inflammatory cytokines in SIRS, intervention at any point of the inflammatory cytokine pathway may lead to unpredictable and unmanageable alteration of the entire pathway. This type of complex neuroendocrine network change in body determines the treatment of sepsis and should not simply utilize the regulation of inflammation/anti-inflammatory cytokine ([@b15-etm-0-0-3354],[@b16-etm-0-0-3354]).

### Function of macrophage active state on sepsis

In sepsis, macrophage can phagocytose pathogenic microorganisms directly, which breaks pathogenic microorganisms through enzyme and bio-activator that by itself produced changes and promotes the process of immune response in body through the activator and its function of antigen presenting ([@b17-etm-0-0-3354]). Thus, macrophages are important immune cells that constitute 'a connecting link between the preceding and the following' ([@b18-etm-0-0-3354]).

A significant feature of macrophages is its obvious heterogeneity, which can form different directions of differentiation according to the micro-environmental state of its tissue. In terms of the conditions of induced differentiation, the original macrophage, also known as M0 macrophage, is formed by the induced differentiation of the early macrophage colony-stimulating factor, which can be divided into classically activated M1 macrophage, and alternatively activated M2 macrophage ([@b19-etm-0-0-3354]). Each has a different pathway of activation, and a series of cytokines from activation induce an immune response to change towards different directions ([@b20-etm-0-0-3354]). M1 macrophage, its production of Th1 immune response and other substances after its activation can damage tissue. However, if the M1 macrophage and related Th1 immune response are not regulated, it may lead to the amplification of body inflammatory reaction with SIRS, severe sepsis, and MODS ([@b19-etm-0-0-3354]). M2 macrophage can be classified as a, b and c according to its function and mechanism, of which, M2a macrophage is activated by IL-4 and IL-13 mainly with the function of promoting wound healing through the generation of extracellular matrix. Thus, IL-4 and IL-13 are the important characteristic cytokines of Th2 immune response ([@b21-etm-0-0-3354]). As mentioned earlier, in various inflammatory diseases of the body, M1/M2 macrophage can reflect a balanced state of inflammation/anti-inflammatory reaction in the body. M1 macrophage and inflammation reaction can remove the pathogenic microorganism by producing various bioactive substances. The M2 macrophage and anti-inflammatory reaction can promote tissue repair and control the inflammatory response, avoiding to some extent the effect of excessive damage ([@b22-etm-0-0-3354]). The M2 macrophages and anti-inflammatory response promote tissue repair and control the inflammatory response to a certain extent to avoid the effect of excessive damage ([@b23-etm-0-0-3354]).

### Effect of recombinant Trichinella 53-kDa protein on macrophages

Previous findings have shown ([@b23-etm-0-0-3354]) that, the enhancement of Th2 immune response or even immunosuppression in patients and animals with sepsis can alleviate the occurrence of certain autoimmune diseases. In a study using chronic trichinization Dark Agouti (DA) rats, it was found that experimental cerebrospinal meningitis was alleviated, and Th2 immune response was activated in the model ([@b19-etm-0-0-3354]). The secretory protein of *Trichinella* can influence immunosuppression *in vitro*, and rTsP53 protein is a type of secretory protein in *Trichinella* that improves the prognosis of sepsis by activating M2 macrophages in the body ([@b21-etm-0-0-3354]).

The results of the present study show that the survival rate of rats in the experimental group was higher than that of the control group at 6 and 12 h, and the difference was statistically significant. The expression ratio of the macrophages received from the different handling methods of the rats in the experimental group was higher than that of the control group, and the difference was statistically significant. The expression level of the Th1-type cytokines IFN-γ and TNF-α of rats in the experimental group was higher than that of the control group. By contrast, the expression level of the Th2-type cytokines IL-4 and IL-13 was higher than that of the control group, and the difference was statistically significant. Therefore, recombinant *Trichinella* 53-kDa protein can increase the survival rate after the infection by CLP sepsis in rats, which may be associated with the improvement of the macrophages and the adjustment of the expression of the Th2 cytokines.

###### 

Comparison of the survival rates in three groups of rats \[case (%)\].

  Groups           Cases   6 h (%)    12 h (%)
  ---------------- ------- ---------- ----------
  Sham operation   5       5          5
  Control          5       2 (40.0)   1 (20.0)
  Experimental     8       6 (75.0)   5 (62.5)
    χ^2^                   3.925      4.152
    P-value                \<0.001    \<0.001

###### 

Comparison of the expression ratio of different macrophages (%).

  Groups         A           B          C           D         E
  -------------- ----------- ---------- ----------- --------- ----------
  Control        81.7±16.4   19.8±5.2   69.4±15.5   2.3±0.2   10.9±2.4
  Experimental   92.6±10.3   32.5±6.4   82.7±14.2   5.2±0.7   16.8±3.3
    t-test       3.526       3.784      4.152       4.829     4.628
    P-value      \<0.001     \<0.001    \<0.001     \<0.001   \<0.001

###### 

Comparison of expression level of Th1- and Th2-type cytokines.

  Groups         IFN-γ (ng/l)   TNF-α (ng/l)   IL-4 (pg/ml)   IL-13 (ng/l)
  -------------- -------------- -------------- -------------- --------------
  Control        725.6±51.2     352.8±25.9     125.3±15.8     24.6±5.9
  Experimental   429.3±46.3     125.3±36.4     365.9±24.3     64.2±3.4
    t-test       4.526          5.268          5.024          5.928
    P-value      \<0.001        \<0.001        \<0.001        \<0.001

[^1]: Contributed equally
